+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Therapeutic Respiratory Devices Market Report 2023-2033

  • PDF Icon

    Report

  • 450 Pages
  • March 2023
  • Region: Global
  • Visiongain
  • ID: 5806158
The Therapeutic Respiratory Devices Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Rising Prevalence of Respiratory Diseases Driving Market Growth

The number of respiratory disorders is growing globally due to a variety of causes such as pollution, lifestyle choices, and smoking. According to WHO, an estimated 65 million individuals have moderate to severe chronic obstructive pulmonary disease (COPD), with around 3 million dying each year, making it the world's third greatest cause of death and the number is growing. About 334 million people worldwide are suffering from asthma, childhood's most frequent chronic condition, impacting 14% of children. The frequency of asthma in children is rising.

The primary factors driving the growth of the therapeutic respiratory devices market are an increase in the frequency and incidence of respiratory disorders, technical innovation, and increasing government and non-governmental organisation support for respiratory disease healthcare awareness. Increasing awareness of respiratory disorders among the general population and governments is predicted to improve the market for respiratory medicine delivery products.

Limited Reimbursements Likely to Hamper Market Growth

Patients' reimbursements are frequently used to pay for medical services. There is now a reimbursement gap in the diagnostic sector as a whole, and in respiratory therapy diagnostics in particular. The reimbursement schemes for PAP equipment and oral appliances differ across Europe and are only applicable in a few countries (devices not covered by insurance represent a small share of the market in the region). Moreover, respiratory care equipment is not fully covered by insurance in the majority of Asian and RoW nations. Over the projected period, high cost of therapeutic respiratory devices is likely to further constrain the market.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the therapeutic respiratory devices market evolving?
  • What is driving and restraining the therapeutic respiratory devices market?
  • How will each therapeutic respiratory devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each therapeutic respiratory devices submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading therapeutic respiratory devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the therapeutic respiratory devices projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of therapeutic respiratory devices projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the therapeutic respiratory devices market?
  • Where is the therapeutic respiratory devices market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the therapeutic respiratory devices market today, and over the next 10 years:

  • Our 450-page report provides 183 tables and 300 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the therapeutic respiratory devices market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, the new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising therapeutic respiratory devices prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product

  • Inhalers
  • Metered Dose Inhalers
  • Dry Powder Inhalers
  • Soft Mist Inhalers
  • Ventilators
  • Adult Ventilators
  • Neonatal Ventilators
  • Humidifiers
  • Heated Humidifiers
  • Passover Humidifiers
  • Integrated Humidifiers
  • Built-in Humidifiers
  • Stand-alone Humidifiers
  • Positive Airway Pressure Devices
  • Continuous Positive Airway Pressure Devices
  • Auto-titrating Positive Airway Pressure Devices
  • Bi-level Positive Airway Pressure Devices
  • Oxygen concentrators
  • Fixed Oxygen Concentrators
  • Portable Oxygen Concentrators
  • Nebulizers
  • Compressor-based Nebulizers
  • Piston-based Hand-held Nebulizers
  • Ultrasonic Nebulizers

Application

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Cystic Fibrosis
  • Acute Respiratory Failure
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Others

End-users

  • Homecare Settings
  • Hospitals
  • Others

Distribution Channel

  • Retail Pharmacies
  • Hospitals Pharmacies
  • Online Pharmacies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the Therapeutic Respiratory Devices Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

3M Health Care
Airsep Corporation (Chart Industries)
AptarGroup, Inc.
AstraZeneca
Becton, Dickinson and Company (BD)
Boehringer Ingelheim International GmbH
Cipla Inc.
Fisher & Paykel Healthcare Limited
GE Healthcare
GF Health Products, Inc.
GSK plc
Hamilton Medical
Invacare
Koninklijke Philips N.V.
Medisana GmbH
Medtronic
Merck & Co., Inc.
Novartis AG
OMRON Corporation
Recipharm AB
ResMed
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Smiths Medical, Inc.
Sunovion Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.

Overall world revenue for Therapeutic Respiratory Devices Market, 2023 to 2033 in terms of value the market will surpass US$63 billion in 2023, this work calculates. We predict strong revenue growth through to 2033. this work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Therapeutic Respiratory Devices Market, 2023 to 2033 report help you?

In summary, this 450+ page report provides you with the following knowledge:
  • Revenue forecasts to 2033 for Therapeutic Respiratory Devices Market, 2023 to 2033 Market, with forecasts for product, application, end-users, and distribution channel, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 18 key national markets - See forecasts for the Therapeutic Respiratory Devices Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the Therapeutic Respiratory Devices Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Therapeutic Respiratory Devices Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Therapeutic Respiratory Devices Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Prevalence of Respiratory Disorders to Fuel Therapeutic Respiratory Devices Market Growth
3.2.1.2 Rising Geriatric Population to Boost Market Growth
3.2.1.3 Technological Advancements Leading to Adoption of Therapeutic Devices in Homecare Settings
3.2.1.4 Increasing Economic Burden of Asthma and Chronic Respiratory Diseases Anticipated to Spur Market Growth
3.2.2 Market Restraining Factors
3.2.2.1 Limited Reimbursements to Hamper Market Growth
3.2.2.2 Lack of Awareness to Restrain Market Growth
3.2.2.3 High Cost of Respiratory Medication Coupled with Under Diagnosis of Condition Likely to Restrain Market Growth
3.2.2.4 Respiratory Devices Manufacturing Complications is Hindering the Growth
3.2.3 Market Opportunities
3.2.3.1 Growing Demand for Home Care Therapeutic Devices
3.2.3.2 Increasing Initiatives by Market Player To Create Awareness about Respiratory Drugs and Treatments
3.2.3.3 Digital Platform for Respiratory Related Therapies to Offer Lucrative Growth Opportunities
3.2.3.4 Increased Demand from Emerging Markets
3.2.4 Market Challenges
3.2.4.1 Asthma Inhalers Are Among the Most Complex Medical Devices in Widespread Use
3.2.4.2 Poor Treatment Adherence
3.2.4.3 Low-Income Countries Face Extra Challenges
3.2.4.4 Disruption of Clinical Trials Due to Pandemic Breakout
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.5.1 Political Factors Impacting Therapeutic Respiratory Devices Market
3.5.2 Economic Factors Impacting Therapeutic Respiratory Devices Market
3.5.3 Social Factors Impacting Therapeutic Respiratory Devices Market
3.5.4 Technological Factors Impacting Therapeutic Respiratory Devices Market
4 Therapeutic Respiratory Devices Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Therapeutic Respiratory Devices Market Size Estimation and Forecast by Product
4.4 Inhalers
4.4.1 Inhalers Market Forecast by Region, 2023-2033 (US$ bn)
4.4.2 Inhalers Market Share by Region, 2023 & 2033 (%)
4.4.3 Metered Dose Inhalers
4.4.3.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.4.3.2 Market Share by Region, 2023 & 2033 (%)
4.4.4 Dry Powder Inhalers
4.4.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.5 Soft Mist Inhalers
4.4.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.4.5.2 Market Share by Region, 2023 & 2033 (%)
4.5 Ventilators
4.5.1 Ventilators Market Forecast by Region, 2023-2033 (US$ bn)
4.5.2 Ventilators Market Share by Region, 2023 & 2033 (%)
4.5.3 Adult Ventilators
4.5.3.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.5.3.2 Market Share by Region, 2023 & 2033 (%)
4.5.4 Neonatal Ventilators
4.5.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.5.4.2 Market Share by Region, 2023 & 2033 (%)
4.6 Humidifiers
4.6.1 Humidifiers Market Forecast by Region, 2023-2033 (US$ bn)
4.6.2 Humidifiers Market Share by Region, 2023 & 2033 (%)
4.6.3 Heated Humidifiers
4.6.3.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.6.3.2 Market Share by Region, 2023 & 2033 (%)
4.6.4 Passover Humidifiers
4.6.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.6.4.2 Market Share by Region, 2023 & 2033 (%)
4.6.5 Integrated Humidifiers
4.6.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.6.5.2 Market Share by Region, 2023 & 2033 (%)
4.6.6 Built-in Humidifiers
4.6.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.6.6.2 Market Share by Region, 2023 & 2033 (%)
4.6.7 Stand-alone Humidifiers
4.6.7.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.6.7.2 Market Share by Region, 2023 & 2033 (%)
4.7 Positive Airway Pressure Devices
4.7.1 Positive Airway Pressure Devices Market Forecast by Region, 2023-2033 (US$ bn)
4.7.2 Positive Airway Pressure Devices Market Share by Region, 2023 & 2033 (%)
4.7.3 Continuous Positive Airway Pressure Devices
4.7.3.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.7.3.2 Market Share by Region, 2023 & 2033 (%)
4.7.4 Auto-titrating Positive Airway Pressure Devices
4.7.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.7.4.2 Market Share by Region, 2023 & 2033 (%)
4.7.5 Bi-level Positive Airway Pressure Devices
4.7.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.7.5.2 Market Share by Region, 2023 & 2033 (%)
4.8 Oxygen Concentrators
4.8.1 Oxygen Concentrators Market Forecast by Region, 2023-2033 (US$ bn)
4.8.2 Oxygen Concentrators Market Share by Region, 2023 & 2033 (%)
4.8.3 Fixed Oxygen Concentrators
4.8.3.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.8.3.2 Market Share by Region, 2023 & 2033 (%)
4.8.4 Portable Oxygen Concentrators
4.8.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.8.4.2 Market Share by Region, 2023 & 2033 (%)
4.9 Nebulizers
4.9.1 Nebulizers Market Forecast by Region, 2023-2033 (US$ bn)
4.9.2 Nebulizers Market Share by Region, 2023 & 2033 (%)
4.9.3 Compressor-based Nebulizers
4.9.3.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.9.3.2 Market Share by Region, 2023 & 2033 (%)
4.9.4 Piston-Based Hand-Held Nebulizers
4.9.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.9.4.2 Market Share by Region, 2023 & 2033 (%)
4.9.5 Ultrasonic Nebulizers
4.9.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.9.5.2 Market Share by Region, 2023 & 2033 (%)
5 Therapeutic Respiratory Devices Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Therapeutic Respiratory Devices Market Size Estimation and Forecast by Application
5.4 Asthma
5.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Chronic Obstructive Pulmonary Disease
5.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Cystic Fibrosis
5.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Acute Respiratory Failure
5.7.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Obstructive Sleep Apnea
5.8.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Respiratory Distress Syndrome
5.9.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.9.2 Market Share by Region, 2023 & 2033 (%)
5.10 Other Applications
5.10.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.10.2 Market Share by Region, 2023 & 2033 (%)
6 Therapeutic Respiratory Devices Market Analysis by End-user
6.1 Key Findings
6.2 End-users Segment: Market Attractiveness Index
6.3 Therapeutic Respiratory Devices Market Size Estimation and Forecast by End-users
6.4 Homecare Settings
6.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Hospitals
6.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Others
6.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.6.2 Market Share by Region, 2023 & 2033 (%)
7 Therapeutic Respiratory Devices Market Analysis by Distribution Channel
7.1 Key Findings
7.2 Distribution Channel Segment: Market Attractiveness Index
7.3 Therapeutic Respiratory Devices Market Size Estimation and Forecast by Distribution Channel
7.4 Retail Pharmacies
7.4.1 Retail Pharmacies Market Forecast by Region, 2023-2033 (US$ bn)
7.4.2 Retail Pharmacies Market Share by Region, 2023 & 2033 (%)
7.5 Hospital Pharmacies
7.5.1 Hospital Pharmacies Market Forecast by Region, 2023-2033 (US$ bn)
7.5.2 Hospital Pharmacies Market Share by Region, 2023 & 2033 (%)
7.6 Online Pharmacies
7.6.1 Online Pharmacy Market Forecast by Region, 2023-2033 (US$ bn)
7.6.2 Online Pharmacy Market Share by Region, 2023 & 2033 (%)
8 Therapeutic Respiratory Devices Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America Therapeutic Respiratory Devices Market Analysis
9.1 Key Findings
9.2 North America Therapeutic Respiratory Devices Market Attractiveness Index
9.3 North America Therapeutic Respiratory Devices Market by Country, 2023, 2028 & 2033 (US$ bn)
9.4 North America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Country
9.5 North America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Product
9.5.1 North America Inhalers Market Size Estimation and Forecast by Type
9.5.2 North America Ventilators Market Size Estimation and Forecast by Type
9.5.3 North America Humidifiers Market Size Estimation and Forecast by Type
9.5.4 North America Positive Airway Pressure (PAP) Devices Market Size Estimation and Forecast by Type
9.5.5 North America Oxygen Concentrators Market Size Estimation and Forecast by Type
9.5.6 North America Nebulizers Market Size Estimation and Forecast by Type
9.6 North America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Application
9.7 North America Therapeutic Respiratory Devices Market Size Estimation and Forecast by End-users
9.8 North America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Distribution Channel
9.9 U.S. Therapeutic Respiratory Devices Market Analysis
9.10 Canada Therapeutic Respiratory Devices Market Analysis
10 Europe Therapeutic Respiratory Devices Market Analysis
10.1 Key Findings
10.2 Europe Therapeutic Respiratory Devices Market Attractiveness Index
10.3 Europe Therapeutic Respiratory Devices Market by Country, 2023, 2028 & 2033 (US$ bn)
10.4 Europe Therapeutic Respiratory Devices Market Size Estimation and Forecast by Country
10.5 Europe Therapeutic Respiratory Devices Market Size Estimation and Forecast by Product
10.5.1 Europe Inhalers Market Size Estimation and Forecast by Type
10.5.2 Europe Ventilators Market Size Estimation and Forecast by Type
10.5.3 Europe Humidifiers Market Size Estimation and Forecast by Type
10.5.4 Europe Positive Airway Pressure (PAP) Devices Market Size Estimation and Forecast by Type
10.5.5 Europe Oxygen Concentrators Market Size Estimation and Forecast by Type
10.5.6 Europe Nebulizers Market Size Estimation and Forecast by Type
10.6 Europe Therapeutic Respiratory Devices Market Size Estimation and Forecast by Application
10.7 Europe Therapeutic Respiratory Devices Market Size Estimation and Forecast by End-users
10.8 Europe Therapeutic Respiratory Devices Market Size Estimation and Forecast by Distribution Channel
10.9 Germany Therapeutic Respiratory Devices Market Analysis
10.10 UK Therapeutic Respiratory Devices Market Analysis
10.11 France Therapeutic Respiratory Devices Market Analysis
10.12 Italy Therapeutic Respiratory Devices Market Analysis
10.13 Spain Therapeutic Respiratory Devices Market Analysis
10.14 Russia Therapeutic Respiratory Devices Market Analysis
10.15 Rest of Europe Therapeutic Respiratory Devices Market Analysis
11 Asia Pacific Therapeutic Respiratory Devices Market Analysis
11.1 Key Findings
11.2 Asia Pacific Therapeutic Respiratory Devices Market Attractiveness Index
11.3 Asia Pacific Therapeutic Respiratory Devices Market by Country, 2023, 2028 & 2033 (US$ bn)
11.4 Asia Pacific Therapeutic Respiratory Devices Market Size Estimation and Forecast by Country
11.5 Asia Pacific Therapeutic Respiratory Devices Market Size Estimation and Forecast by Product
11.5.1 Asia Pacific Inhalers Market Size Estimation and Forecast by Type
11.5.2 Asia Pacific Ventilators Market Size Estimation and Forecast by Type
11.5.3 Asia Pacific Humidifiers Market Size Estimation and Forecast by Type
11.5.4 Asia Pacific Positive Airway Pressure (PAP) Devices Market Size Estimation and Forecast by Type
11.5.5 Asia Pacific Oxygen Concentrators Market Size Estimation and Forecast by Type
11.5.6 Asia Pacific Nebulizers Market Size Estimation and Forecast by Type
11.6 Asia Pacific Therapeutic Respiratory Devices Market Size Estimation and Forecast by Application
11.7 Asia Pacific Therapeutic Respiratory Devices Market Size Estimation and Forecast by End-users
11.8 Asia Pacific Therapeutic Respiratory Devices Market Size Estimation and Forecast by Distribution Channel
11.9 Japan Therapeutic Respiratory Devices Market Analysis
11.10 China Therapeutic Respiratory Devices Market Analysis
11.11 India Therapeutic Respiratory Devices Market Analysis
11.12 Australia Therapeutic Respiratory Devices Market Analysis
11.13 South Korea Therapeutic Respiratory Devices Market Analysis
11.14 Rest of Asia Pacific Therapeutic Respiratory Devices Market Analysis
12 Latin America Therapeutic Respiratory Devices Market Analysis
12.1 Key Findings
12.2 Latin America Therapeutic Respiratory Devices Market Attractiveness Index
12.3 Latin America Therapeutic Respiratory Devices Market by Country, 2023, 2028 & 2033 (US$ bn)
12.4 Latin America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Country
12.5 Latin America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Product
12.5.1 Latin America Inhalers Market Size Estimation and Forecast by Type
12.5.2 Latin America Ventilators Market Size Estimation and Forecast by Type
12.5.3 Latin America Humidifiers Market Size Estimation and Forecast by Type
12.5.4 Latin America Positive Airway Pressure (PAP) Devices Market Size Estimation and Forecast by Type
12.5.5 Latin America Oxygen Concentrators Market Size Estimation and Forecast by Type
12.5.6 Latin America Nebulizers Market Size Estimation and Forecast by Type
12.6 Latin America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Application
12.7 Latin America Therapeutic Respiratory Devices Market Size Estimation and Forecast by End-users
12.8 Latin America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Distribution Channel
12.9 Brazil Therapeutic Respiratory Devices Market Analysis
12.10 Mexico Therapeutic Respiratory Devices Market Analysis
12.11 Argentina Therapeutic Respiratory Devices Market Analysis
12.12 Rest of Latin America Therapeutic Respiratory Devices Market Analysis
13 MEA Therapeutic Respiratory Devices Market Analysis
13.1 Key Findings
13.2 MEA Therapeutic Respiratory Devices Market Attractiveness Index
13.3 MEA Therapeutic Respiratory Devices Market by Country, 2023, 2028 & 2033 (US$ bn)
13.4 MEA Therapeutic Respiratory Devices Market Size Estimation and Forecast by Country
13.5 MEA Therapeutic Respiratory Devices Market Size Estimation and Forecast by Product
13.5.1 MEA Inhalers Market Size Estimation and Forecast by Type
13.5.2 MEA Ventilators Market Size Estimation and Forecast by Type
13.5.3 MEA Humidifiers Market Size Estimation and Forecast by Type
13.5.4 MEA Positive Airway Pressure (PAP) Devices Market Size Estimation and Forecast by Type
13.5.5 MEA Oxygen Concentrators Market Size Estimation and Forecast by Type
13.5.6 MEA Nebulizers Market Size Estimation and Forecast by Type
13.6 MEA Therapeutic Respiratory Devices Market Size Estimation and Forecast by Application
13.7 MEA Therapeutic Respiratory Devices Market Size Estimation and Forecast by End-users
13.8 MEA Therapeutic Respiratory Devices Market Size Estimation and Forecast by Distribution Channel
13.9 GCC Therapeutic Respiratory Devices Market Analysis
13.10 South Africa Therapeutic Respiratory Devices Market Analysis
13.11 Rest of MEA Therapeutic Respiratory Devices Market Analysis
14 Company Profiles
14.1 Company Share Analysis
14.2 Strategic Outlook
14.3 GSK plc
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2018-2022
14.3.3.2 Regional Revenue/Market Shares, 2022
14.3.3.3 Segmental Revenue/Market Shares, 2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Koninklijke Philips N.V.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2018-2022
14.4.3.2 Regional Revenue/Market Shares, 2022
14.4.3.3 Segmental Revenue/Market Shares, 2022
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Boehringer Ingelheim International GmbH
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2017-2021
14.5.3.2 Regional Revenue/Market Shares, 2021
14.5.3.3 Segmental Revenue/Market Shares, 2022
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 GE Healthcare
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2018-2022
14.6.3.2 Regional Revenue/Market Shares, 2022
14.6.3.3 Segmental Revenue/Market Shares, 2022
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 3M Health Care
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2018-2022
14.7.3.2 Segmental Revenue/Market Shares, 2022
14.7.4 Product Benchmarking
14.8 AstraZeneca
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2018-2022
14.8.3.2 Regional Revenue/Market Shares, 2022
14.8.3.3 Segmental Revenue/Market Shares, 2022
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 Merck & Co., Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2018-2022
14.9.3.2 Regional Revenue/Market Shares, 2022
14.9.3.3 Segmental Revenue/Market Shares, 2022
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 Novartis AG
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2018-2022
14.10.3.2 Regional Revenue/Market Shares, 2022
14.10.3.3 Segmental Revenue/Market Shares, 2022
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 OMRON Corporation
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2018-2022
14.11.3.2 Regional Revenue/Market Shares, 2022
14.11.3.3 Segmental Revenue/Market Shares, 2022
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 Sunovion Pharmaceuticals Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2017-2021
14.12.3.2 Regional Revenue/Market Shares, 2021
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 Teva Pharmaceutical Industries Ltd.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2018-2022
14.13.3.2 Regional Revenue/Market Shares, 2022
14.13.4 Product Benchmarking
14.13.5 Strategic Outlook
14.14 Cipla Inc.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2018-2022
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook
14.15 Recipharm AB
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2017-2021
14.15.3.2 Regional Revenue/Market Shares, 2021
14.15.3.3 Segmental Revenue/Market Shares, 2021
14.15.4 Product Benchmarking
14.15.5 Strategic Outlook
14.16 Medisana GmbH
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Product Benchmarking
14.17 GF Health Products, Inc.
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Product Benchmarking
14.18 AptarGroup, Inc.
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis
14.18.3.1 Net Revenue, 2018-2022
14.18.3.2 Regional Revenue/Market Shares, 2022
14.18.3.3 Segmental Revenue/Market Shares, 2022
14.18.4 Product Benchmarking
14.18.5 Strategic Outlook
14.19 Airsep Corporation (Chart Industries)
14.19.1 Company Snapshot
14.19.2 Company Overview
14.19.3 Financial Analysis
14.19.3.1 Net Revenue, 2018-2022
14.19.3.2 Regional Market Shares, 2022
14.19.3.3 Segmental Market Shares, 2022
14.19.4 Product Benchmarking
14.20 Becton, Dickinson and Company (BD)
14.20.1 Company Snapshot
14.20.2 Company Overview
14.20.3 Product Benchmarking
14.20.4 Financial Analysis
14.20.4.1 Net Revenue, 2018-2022
14.20.4.2 Regional Market Shares, 2022
14.20.4.3 Segmental Market Shares, 2022
14.20.5 Strategic Outlook
14.21 Fisher & Paykel Healthcare Limited
14.21.1 Company Snapshot
14.21.2 Company Overview
14.21.3 Product Benchmarking
14.21.4 Strategic Outlook
14.22 Hamilton Medical
14.22.1 Company Snapshot
14.22.2 Company Overview
14.22.3 Product Benchmarking
14.23 Invacare
14.23.1 Company Snapshot
14.23.2 Company Overview
14.23.3 Financial Analysis
14.23.3.1 Net Revenue, 2018-2022
14.23.3.2 Regional Market Shares, 2022
14.23.3.3 Segmental Market Shares, 2022
14.23.4 Product Benchmarking
14.24 Medtronic
14.24.1 Company Snapshot
14.24.2 Company Overview
14.24.3 Financial Analysis
14.24.3.1 Net Revenue, 2019-2022
14.24.3.2 Regional Revenue/Market Shares, 2022
14.24.4 Product Benchmarking
14.24.5 Strategic Outlook
14.25 ResMed
14.25.1 Company Snapshot
14.25.2 Company Overview
14.25.3 Financial Analysis
14.25.3.1 Net Revenue, 2019-2022
14.25.3.2 Regional Revenue/Market Shares, 2022
14.25.4 Product Benchmarking
14.25.5 Strategic Outlook
14.26 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
14.26.1 Company Snapshot
14.26.2 Company Overview
14.26.3 Financial Analysis
14.26.3.1 Net Revenue, 2017-2021
14.26.3.2 Regional Revenue/Market Shares, 2022
14.26.4 Product Benchmarking
14.26.5 Strategic Outlook
14.27 Smiths Medical, Inc.
14.27.1 Company Snapshot
14.27.2 Company Overview
14.27.3 Financial Analysis
14.27.3.1 Net Revenue, 2017-2021
14.27.3.2 Regional Revenue/Market Shares, 2022
14.27.4 Product Benchmarking
14.27.5 Strategic Outlook
15 Conclusion and Recommendations
15.1 Concluding Remarks from
15.2 Recommendations for Market Players

Companies Mentioned

  • 3M Health Care
  • Airsep Corporation (Chart Industries)
  • AptarGroup, Inc.
  • AstraZeneca
  • Becton, Dickinson and Company (BD)
  • Boehringer Ingelheim International GmbH
  • Cipla Inc.
  • Fisher & Paykel Healthcare Limited
  • GE Healthcare
  • GF Health Products, Inc.
  • GSK plc
  • Hamilton Medical
  • Invacare
  • Koninklijke Philips N.V.
  • Medisana GmbH
  • Medtronic
  • Merck & Co., Inc.
  • Novartis AG
  • OMRON Corporation
  • Recipharm AB
  • ResMed
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Smiths Medical, Inc.
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Actavis Generics
  • Adherium Limited
  • Ai Biomed
  • AirPhysio
  • Alnylam
  • Alveofit
  • Apollo Group
  • ArtiQ
  • BIAL
  • BIOCORP
  • BreatheSuite
  • Carepod
  • Chiesi Group
  • Cohero Health
  • Consort Medical
  • Covis Pharma Group
  • CUBEX LLC
  • Evelo Biosciences, Inc.
  • Fluidda
  • Glenmark Pharmaceuticals
  • H&T Presspart
  • HeartWare International, Inc.
  • Honeywell
  • Iconovo AB
  • Ikaria Australia Pty Ltd.
  • Inspira Pharmaceuticals
  • iPharma Laboratories
  • Ivera Medical Corp.
  • Leyden Labs
  • Lifebit Biotech, Ltd.
  • Lupin
  • Mallinckrodt International Holdings S.a.r.l.
  • Masimo
  • Meditab Specialities Ltd.
  • Medsmart
  • Medspray BV
  • Monaghan Medical
  • Nanopharm
  • NEOGEN
  • Neurimmune
  • NeuroRx
  • Nihon Kohden OrangeMed, Inc.
  • NuvoAir
  • Nyxoah SA
  • Otsuka
  • Pharmaxis
  • Propeller Health
  • Relief Therapeutics
  • Rubicon Research Private Limited
  • Sandoz
  • Scanwell Health
  • Senzer Pharmaceuticals
  • Sonmol
  • Sumitomo Dainippon Pharma America, Inc.
  • SunMed
  • Tencent AI Lab
  • TOA Pharmaceutical Co., Ltd.
  • Transpire Bio
  • Treo Solutions LLC
  • Trudell Medical Limited
  • Urovant Sciences
  • Valeo Pharma Inc.
  • Vectura
  • American Lung Association
  • Arab Health of Allergy, Asthma & Immunology (AAAAI)
  • Asthma and Allergy Foundation of America
  • Australian Bureau of Statistics
  • Barcelona Institute of Global Health
  • Biomedical Advanced Research and Development Authority (BARDA)
  • British Lung Foundation (BLF)
  • British Thoracic Society
  • Centers for Disease Control and Prevention (CDC)
  • Cystic Fibrosis Patient Registry
  • Drugs Controller General of India (DCGI)
  • Eurohealth
  • European Commission
  • GAVI Alliance
  • German Health Insurance Agency
  • Getting It Right First Time (GIRFT)
  • Institute for Health Metrics and Evaluation (IHME)
  • International Study of Asthma and Allergies in Childhood (ISAAC)
  • Japanese Respiratory Society
  • Korea Disease Control and Prevention Agency (KDCA)
  • Ministry of Health of Seguro Popular
  • National Asthma Council Australia
  • National Center for Biotechnology Information (NCBI)
  • National Health Service
  • National Heart, Lung, and Blood Institute (NHLBI)
  • National Institute of Health (NIH)
  • Occupational Lung Disease Statistics
  • Primary Care Respiratory Society (PCRS)
  • U.S. Census Bureau
  • U.S. Food and Drug Administration
  • U.S. Health and Human Services
  • World Health Organization (WHO)